Business & Tech
Ameridose Shares Owners With Framingham Company at Center of Meningitis Outbreak
A PR firm says Ameridose and the New England Compounding Center operate separately.
The owners of the Framingham pharmacy connected with the multi-state fungal meningitis outbreak own Ameridose in Westborough as well, the Boston Herald reports.
Ameridose, at 201 Flanders Rd., "had a drug recall in 2008, state and federal records show," the Herald reports.
Owners Gregory Conigliaro and Barry J. Cadden also own the New England Compounding Center in Framingham.
Interested in local real estate?Subscribe to Patch's new newsletter to be the first to know about open houses, new listings and more.
However, "A public relations firm representing the NECC and Ameridose owners said in a statement yesterday, 'Although there is common ownership, the two companies operate under separate registrations and different licensure,'" the Herald reports.
According to the firm's website, "Ameridose offers over 2,200 sterile admixed IV solutions and prefilled oral syringes so that we are able to meet all your hospital pharmacy outsourcing needs."
Interested in local real estate?Subscribe to Patch's new newsletter to be the first to know about open houses, new listings and more.
Steroid injections made at the New England Compounding Center have been linked to a meningitis outbreak over several states.
Monday, Framingham Patch reported that eight people have died and 105 people have been infected.
Over the weekend, the New England Compounding Center voluntarily recalled all 1,200 products it makes.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.
